Compare MWA & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MWA | XENE |
|---|---|---|
| Founded | 1857 | 1996 |
| Country | United States | Canada |
| Employees | 3500 | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 5.2B |
| IPO Year | 2006 | 2014 |
| Metric | MWA | XENE |
|---|---|---|
| Price | $25.30 | $54.47 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 11 |
| Target Price | $30.50 | ★ $68.55 |
| AVG Volume (30 Days) | 972.4K | ★ 998.9K |
| Earning Date | 05-05-2026 | 05-08-2026 |
| Dividend Yield | ★ 1.01% | N/A |
| EPS Growth | ★ 64.86 | N/A |
| EPS | ★ 0.65 | N/A |
| Revenue | ★ $1,429,700,000.00 | $311,000.00 |
| Revenue This Year | $4.78 | N/A |
| Revenue Next Year | $4.27 | $2,496.48 |
| P/E Ratio | $38.95 | ★ N/A |
| Revenue Growth | ★ 8.75 | N/A |
| 52 Week Low | $22.74 | $28.97 |
| 52 Week High | $31.00 | $62.91 |
| Indicator | MWA | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 38.85 | 46.02 |
| Support Level | $24.75 | $52.90 |
| Resistance Level | $25.41 | $59.43 |
| Average True Range (ATR) | 0.55 | 1.48 |
| MACD | 0.04 | -0.10 |
| Stochastic Oscillator | 30.00 | 36.54 |
Mueller Water Products Inc is a U.S.-based company that manufactures and sells products and services used in the transmission, distribution, and measurement of water. The company operates in two segments: Water Flow Solutions and Water Management Solutions. The Water Flow Solutions segment, which derives maximum revenue for the company, includes products like iron gate valves, specialty valves, and service brass products. Water Management Solutions' portfolio includes fire hydrants, repair and installation, natural gas, metering, leak detection, and pressure management and control products and solutions. Geographically, the company derives a majority of its revenue from the United States and the rest from Canada and other international locations.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.